Abstract
Warton’s jelly-derived Mesenchymal stem cells (WJ-MSCs) play key roles in improving nerve regeneration in acellular nerve grafts (ANGs); however, the mechanism of WJ-MSCs-related nerve regeneration remains unclear. This study investigated how WJ-MSCs contribute to peripheral nerve regeneration by examining immunomodulatory and paracrine effects, and differentiation potential. To this end, WJ-MSCs were isolated from umbilical cords, and ANGs (control) or WJ-MSCs-loaded ANGs (WJ-MSCs group) were transplanted in injury animal model. Functional recovery was evaluated by ankle angle and tetanic force measurements up to 16 weeks post-surgery. Tissue biopsies at 3, 7, and 14 days post-transplantation were used to analyze macrophage markers and interleukin (IL) levels, paracrine effects, and MSC differentiation potential by quantitative real-time polymerase chain reaction (RT-qPCR) and immunofluorescence staining. The WJ-MSCs group showed significantly higher ankle angle at 4 weeks and higher isometric tetanic force at 16 weeks, and increased expression of CD206 and IL10 at 7 or 14 days than the control group. Increased levels of neurotrophic and vascular growth factors were observed at 14 days. The WJ-MSCs group showed higher expression levels of S100β; however, the co-staining of human nuclei was faint. This study demonstrates that WJ-MSCs' immunomodulation and paracrine actions contribute to peripheral nerve regeneration more than their differentiation potential.
Similar content being viewed by others
Introduction
Autologous nerve graft is the standard treatment option for peripheral nerve defect reconstruction; however, donor-side morbidities, limited donor tissue length, and donor–recipient size mismatch limit its use1,2. Therefore, alternative materials were introduced. Among them, acellular nerve grafts (ANGs) have advantages in retaining the microstructure of extracellular matrix (ECM) proteins2,3. However, ANGs alone have limited regeneration potential, especially in large nerve defects, which originates from the lack of neuronal support cells including Schwann cells (SCs)4,5.
Previous studies revealed the efficacy of SCs for enhancing nerve regeneration after nerve graft4,6. However, the clinical application of SCs to nerve graft is limited by their limited resources and technically challenging culture process5,7. To overcome these limitations, mesenchymal stem cells (MSCs), which are a kind of precursor cells to SCs, are being considered as an alternative8.
MSCs are self-renewal multipotent precursor cells derived from various tissues (e.g., bone marrows, adipose tissues, skin, and umbilical cords)9. Bone marrows-MSCs (BM-MSCs) are the most widely investigated type of MSCs; however, their low yield and high degree of invasiveness have limited their clinical applicability10. Adipose tissue-derived MSCs (AMSCs) have several advantages over BMSCs, including lower degree of invasiveness for acquisition, and rapid rate of expansion in vitro; however, the proliferation rate and differentiation potential of these cells decrease with increasing donor age11,12. Among various MSCs, WJ-MSCs, which are isolated from human umbilical cords as waste tissue, have multiple advantages, including a non-invasive harvesting method, high proliferation rate, and high expression of pluripotency markers5,13,14.
One previous study revealed that WJ-MSCs could differentiate to SC-like cells (SCLCs) to aid nerve regeneration in peripheral injury animal model5. However, research on the mechanism of MSCs related to peripheral nerve regeneration is insufficient, and the mechanism of MSCs differentiation and secretion of neurotransmitters in peripheral nerves are yet to be clarified15. In the present study, the mechanisms involved in peripheral nerve regeneration by WJ-MSCs were investigated, focusing on three perspectives: immunomodulatory effects, paracrine effects, and differentiation potential.
Results
Functional assessment and analysis of toluidine blue staining
The ankle angles at the toe‐off phase at 4, 8, 12, and 16 weeks were 57.8° ± 3.1°, 71.0° ± 1.67°, 68.2° ± 4.5°, and 83.4° ± 2.7° for the ANG group, and 72.8° ± 3.8°, 75.8° ± 6.3°, 76.1° ± 2.5°, and 92.0° ± 5.0° for the ANG + WJ-MSCs group (Fig. 1A). Although the WJ-MSCs group exhibited higher ankle angles than the ANG group, statistical significance was observed at 4 weeks postoperatively (p = 0.010). Measurement of the isometric tetanic force at 16 weeks postoperatively revealed that the ANG + WJ-MSCs group exhibited a statistically significant recovery rate than the ANG group (43.4 ± 6.2% vs. 23.4 ± 7.1%, p = 0.029; Fig. 1B). Toluidine Blue staining was employed to observe the histological structures of axons and nerve fibers (Fig. 1C). Results revealed that the total axon counts were significantly higher in the ANG + WJ-MSCs group than in the ANG group (1412.0 ± 60.7 vs. 1098.0 ± 78.2, p = 0.003; Fig. 1D).
Expression of macrophage markers
The mRNA expression levels of CD206 and IL10 were not significantly different between the two groups at 3 days postoperatively. The mRNA expression level of CD206 was significantly higher in the WJ-MSCs group than in the control group at 14 days postoperatively (p < 0.05). Meanwhile, the mRNA expression level of IL10 was significantly higher in the WJ-MSCs group than in the control group at 7 and 14 days postoperatively (p < 0.05) (Fig. 2A). In the analysis of protein expression levels, CD206 expression was maintained at a higher level in the WJ -MSCs group than in the control group until 14 days postoperatively. However, CD68 expression was not different between the two groups (Fig. 2B).
Expression of neurotrophic and angiogenesis factors
The mRNA expression levels of the nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factors (VEGF) were not significantly different between the two groups at 3 and 7 days postoperatively. However, the mRNA expression levels of BDNF and VEGF were significantly higher in the WJ-MSCs group than in the control group at 14 days postoperatively (p < 0.05) (Fig. 3A). In addition, immunofluorescence staining confirmed that the protein levels of NGF, BDNF, and VEGF were higher in the WJ-MSCs group than in the control group, showing a similar pattern to RNA expression (Fig. 3B).
Expression of SC markers and results of double-staining with human nuclei and S100β
The mRNA expression levels of S100β and myelin basic protein (MBP) were not significantly different between the two groups at 3 days postoperatively. However, they were significantly higher in the WJ-MSCs group than in the control group at 7 days postoperatively (p < 0.05). This difference was maintained until 14 days postoperatively only for MBP (p < 0.05). In addition, immunofluorescence staining showed similar results (Fig. 4). Double-staining of human nuclei and S100β in the WJ-MSCs group showed that the red-stained human nuclei and green-stained S100β did not co-colonize at 7 days postoperatively (Fig. 5).
Discussion
Over the years, MSCs have attracted considerable interest in regenerative medicine; they are being considered in in vitro and in vivo studies to test their efficacy in enhancing peripheral nerve regeneration16. Additionally, they are believed to replace injured tissue cells via differentiation and maximize the intrinsic regenerative capacity of injured tissues by producing several growth factors and cytokines17. The mechanisms of MSCs for enhancing nerve regeneration depend on their type; however, no in-depth studies have evaluated these mechanisms in WJ-MSCs18.
After peripheral nerve injury, SCs trigger a series of immunoregulatory reactions by secreting cytokines and recruiting various immune cells19. In this process, MSCs can produce various immunoregulatory factors that modulate immune function (immunomodulatory effects)20. This phenomenon has been revealed in several types of MSCs21, but not in WJ-MSCs. Generally, macrophages can be divided into two groups: M1 macrophages, which stimulate local inflammation and remove debris at the injury site, and M2 macrophages, which play an important role in wound healing and tissue repair22. In this study, the WJ-MSCs group showed significantly higher level of macrophage markers, including CD206, which is a marker for an anti-inflammatory M2 macrophage23 and IL10, which is known for its anti-inflammatory properties24. However, the protein expression level of CD68, as a pan-macrophage marker that reflects macrophage quantities of M1 and M225,26, was not significantly different between the two groups. This finding indicates that the number of recruited macrophages was not significantly different. The roles of M1 and M2 macrophages are nuanced and flexible27. Pro-inflammatory macrophages can even convert to anti-inflammatory phenotypes, demonstrating their remarkable plasticity28. WJ-MSCs can enhance the polarization of macrophages toward the M2 phenotype, promoting an anti-inflammatory environment29. Anti-inflammatory factors have several beneficial effects on nerve regeneration, including activating and proliferating SCs30, promoting angiogenesis31, and modulating the ECM environment to favor axonal growth32.
It is known that MSCs secrete various factors that promote nerve cell survival and axonal growth, showing increased paracrine effects18,33. In this study, the WJ-MSCs group showed significantly higher levels of neurotrophic (BDNF and NGF) and angiogenesis factors (VEGF). Additionally, BDNF is a neurotrophic factor that supports neuronal survival, growth, and differentiation34. After peripheral nerve injury, BDNF is upregulated and sustained over the course of weeks35,36. It promotes axonal growth, provides essential cues for axonal sprouting, and directs axonal regeneration toward their target, facilitating functional recovery37,38. Similar to BDNF, NGF stimulate neuronal survival, promote axonal growth, and exerts a neuroprotective effect against nerve system disorders39,40. Further, VEGF is a potent angiogenic factor that plays a critical role in angiogenesis, which is essential for the revascularization of regenerating nerves41. It exhibits direct neuroprotective effects on neurons42 and enhances SC proliferation and migration after peripheral nerve injury43. In addition to BDNF and VEGF, WJ-MSCs secrete various growth factors and cytokines that collectively contribute to paracrine effects and promote nerve regeneration. These factors include NGF, fibroblast growth factor, and insulin-like growth factor18.
In this study, the WJ-MSCs group exhibited higher levels of SCs markers than the control group. To determine the reason for the higher levels of SCs markers (S100β) in the WJ-MSC group, we performed the double staining of human nuclei and the S100β antibodies. If the transplanted WJ-MSCs were differentiated into Schwann cells, the expression of S100β and h nuclei, as a specific marker of human cells, would have co-localized. However, double-staining of human nuclei and S100β in the WJ-MSCs group did not show co-colonization, suggesting that the observed increase in the SC markers may be attributed to the recruitment of host SCs rather than the direct differentiation of WJ-MSCs into SCs. WJ-MSCs can differentiate into SCLCs in vitro, which promote peripheral nerve regeneration in ANGs in vivo5. However, the differentiation of MSCs into SCLCs is a time-consuming process and typically requires the use of specific growth factors and signaling molecules44. To enhance peripheral nerve regeneration by utilizing the differentiation potential of MSCs, the in vitro application of differentiated MSCs may be more beneficial than using naïve MSCs7. Further studies are needed to confirm whether the benefits obtained from the direct differentiation of MSCs, when applied after differentiation, are greater than those obtained through the immunomodulatory and paracrine effects of naïve MSCs in peripheral nerve regeneration.
This study has several limitations. First, although we observed elevated levels of several markers in the WJ-MSCs group compared to the control group, we did not assess the specific biological role of each marker. Further experimental validation is necessary to confirm their effectiveness. Second, we were unable to discover new target gene and related to pathways using RNA-Seq. Discovering new marker and signaling, knocking out or overexpressing them, and proving their relationship with peripheral nerve regeneration will lead to more innovative research.
In conclusion, the present study demonstrates that the mechanism of WJ-MSCs in enhancing peripheral nerve regeneration is because of their immunomodulatory and paracrine effects rather than their differentiation potential. This finding will be useful for understanding the mechanism of MSCs for enhancing peripheral nerve regeneration.
Materials and methods
Preparation and culture of human WJ-MSCs
This study was approved by the Institutional Review Board of Asan Medical Center (No. 2015–0303), and the WJ-MSCs were provided by the Stem Cell Center, Asan Institute for Life Sciences, Seoul, Korea. All experiments were performed in accordance with relevant guidelines and regulations. Informed consent from the mothers was obtained for the use of umbilical cords. Umbilical cords were cut into 0.3–1.0 cm pieces without blood vessels. The matrix was minced and transferred to culture dishes in minimal essential medium supplemented with 10% fetal bovine serum and an antibiotic–antimycotic mixture at 37 °C in a 5% CO2 incubator in vitro as described previously45. When the cells reached 80% confluency, they were replated at a 1:3 split ratio.
Preparation of ANGs
This study complied with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee of Asan Medical Center and Ulsan University College of Medicine (No. 2017-12-127), and all the following methods were performed in accordance with the relevant guidelines and regulations. After isoflurane induction, rats were euthanized by CO2 inhalation. Sciatic nerve segments (10 mm in length) were harvested from male Sprague–Dawley (SD) rats (7–8 weeks old, weight 250–350 g) (Orient Bio Inc., Seongnam, Korea). To prepare ANGs, sciatic nerve pieces were decellularized using a series of detergents as described by Shin et al.2. Briefly, the nerves were treated with detergents, including aprotinin, CHAPS, and DNase and RNase solutions. Then, the decellularized segments were washed several times with phosphate-buffered saline (PBS) to remove residual reagents and stored in PBS at 4 °C until use. All solutions were autoclaved or filter-sterilized before use.
Surgical procedure
Seventy-four adult male SD rats were randomly assigned to two groups: WJ-MSCs group (which was implanted with WJ-MSCs-laden ANG; n = 37) and control group (which was implanted with ANG only; n = 37). After anesthetization, the left sciatic nerve of rats was exposed and transected, and 10 mm of the nerve was removed. The 10-mm piece of WJ-MSCs-laden ANG or ANG was sutured using 9‐0 nylon (Ethicon, Somerville, NY) under a microscope.
Functional assessment
Seven rats were selected from each group, and their ankle angles at the toe‐off phase were measured at 4, 8, 12, and 16 weeks postoperatively to evaluate serial functional recovery. A walking track (length 1 m, width 10 cm, and height 10 cm) was built for this test. During the test, video was acquired with a digital camera (Canon SX730HS, Canon, Tokyo, Japan) at a distance of 1 m and calibrated to prevent optical distortion. Records were repeated until three satisfactory trials were obtained per rat. The ankle angle at the toe‐off phase was measured at maximal plantar flexion in the experimental lateral ankle joint. After the foot and leg segments were manually identified in the video frames, the ankle angles at the toe‐off phase were displayed in degrees.
All rats were anesthetized at 16 weeks postoperatively, and the maximum isometric tetanic force was measured. The sciatic nerve was fully exposed through previous operation incision, and another skin incision was made anterior to the ankle to expose and transect the tibialis anterior (TA) tendon distally. The TA tendon was connected to a force transducer using a custom clamp with the knee and ankle joints immobilized to a platform. A bipolar stimulator (Grass S88, Grass Instrument Corp, Quincy, MA) was used to generate stimulus and processed on a computer using LabVIEW software (National Instruments, Austin, TX). All contractions were performed at supramaximal voltage to ensure maximal activation of all TA motor units. The strength of muscles was standardized as a percentage of the value from the contralateral side.
Analysis using toluidine blue staining
Sciatic nerve axonal regeneration in each group was directly examined using toluidine blue staining at 16 weeks postoperatively. The implanted sciatic nerves were harvested by including the distal sites, and 2.5% glutaraldehyde solution was used for fixation. The harvested nerves were further fixed in 1% osmium tetroxide, dehydrated in ethanol, and embedded in EPON resin (Miller-Stephenson Chemical Co., Sylmar, CA, USA). Cross-sections (1 μm thick) were stained with toluidine blue to visualize myelin with light microscopy. Digital images of nonoverlapping fields were taken at 400 × magnification using unbiased random sampling. The total number of myelinated axons was calculated using ImageJ software (National Institutes of Health, Bethesda, MD).
Quantitative real-time polymerase chain reaction (RT-qPCR)
RT-qPCR was performed to evaluate the mRNA expression levels of factors related to peripheral nerve regeneration. First, macrophage markers (CD206 and interleukin 10 [IL10]) were assessed to investigate the immunomodulatory effects of WJ-MSCs. Second, NGF, BDNF, and VEGF were assessed to analyze the paracrine effects of WJ-MSCs on ANGs. Third, SC markers (S100β and MBP) were assessed to confirm the recruitment of SCs by WJ-MSCs in ANGs. All experiments were performed using nerve grafts harvested from five rats in each group at 3, 7, and 14 days postoperatively. Gene expressions were analyzed as described previously5. Total RNA was isolated from ANGs or WJ-MSCs-laden ANGs using TRIzol (Thermo Fisher Scientific). Approximately 1 μg of total RNA was used for cDNA synthesis using a first-strand cDNA synthesis kit. Quantitative estimation of mRNA expression was conducted using the ABI 7500 Fast Real-Time PCR System (Applied Biosystems/Thermo Fisher Scientific). All experiments were performed in triplicates and independently repeated more than three times. The following primers were used: CD206 (forward, TTA CTT TAA GGG GGC GTG TG; reverse, AGT TGG TTG GGG AGT GTC AG), IL10 (forward, CTC CAC CTG GCA AAC AAA AT; reverse, CTG CCT AGC CCA CAA AGA AG), NGF (forward, ACT CGG CTC CTT TGA GTT GA; reverse, CCC GTC CTA CAG AAG CAG AG), BDNF (forward, GAA GGT GAG GAA AGC AGC AC; reverse, TGC ACA GTC ATC TGG AAA GC), VEGF (forward, TGC TTC CTA GTG GGC TCT GT; reverse, CAC ACA TAC ACT CCG GCA TC), S100β (forward, GAA TTG GGG CAG AGA AAT GA; reverse, GGC TTG AGC TTC TTG GAA TG), MBP (forward, AAT GTT TCA GGG CAC CGT AG; reverse, AAA AAC CAG CCA GCT GAG AA), and GAPDH (forward, ATG GTG AAG GTC CCT GTG AAC G; reverse, CTT GCC GTG GGT AGA GTC AT). The comparative Ct method (2−ΔΔCt)46 was used to analyze the relative amount of gene expression.
Immunofluorescence staining
The protein levels of CD206, CD68, NGF, BDNF, VEGF, and S100β were evaluated using immunofluorescence staining at 3, 7, and 14 days postoperatively. CD68 (a total marker of all macrophages) was analyzed to identify and quantify macrophages. In addition, double-staining for human nuclei and S100β was performed only in the WJ-MSCs group at 3 and 7 days postoperatively to investigate the differentiation potential of WJ-MSCs in ANGs. All experiments were performed using nerve grafts harvested from five rats in each group.
The grafts were snap-frozen in liquid nitrogen with frozen section compound (Leica Biosystems, Wetzlar, Germany) as described previously47. Samples were cut into 6-μm-thick cross-sections using a Cryo-Star HM560 freezing microtome (Thermo Fisher Scientific). After fixation, sections were permeabilized and then blocked with 10% normal goat serum. Thereafter, they were incubated overnight with the primary antibody at 4 °C. The following antibodies were used: anti-CD206 (ab64693; Abcam, Cambridge, UK), anti-CD68 (ab201340; Abcam), anti-NGF (ab6199; Abcam), anti-BDNF (ab108319; Abcam), anti-VEGF (ab1316), anti-S100b (ab52642; Abcam), and anti-hNuclei (MAB1281; Millipore, Burlington, MA, USA). Secondary antibodies, anti-rabbit Alexa 555 (A32732, Invitrogen), and anti-mouse Alexa 546 (Invitrogen A11003), were applied for 1 h at room temperature in the dark. Finally, 4′,6-diamidino-2-phenylindole was used to counterstain nuclei. Analysis of staining was performed using an LSM-810 confocal microscope (Zeiss, Oberkochen, Germany) at 100 × magnification.
Statistical analysis
All experiments were repeated three times or more. Values are presented as mean ± standard error of the mean (SEM). Statistical significance was considered at p < 0.05. All statistical analyses were performed using Student’s t-test in IBM SPSS Statistics for Windows v. 27.0 (IBM, USA).
Data availability
All data analyzed during this study are available from the corresponding author on reasonable request.
References
Lee, S. K. & Wolfe, S. W. Peripheral nerve injury and repair. J. Am. Acad. Orthop. Surg. 8, 243–252 (2000).
Shin, Y. H., Park, S. Y. & Kim, J. K. Comparison of systematically combined detergent and nuclease-based decellularization methods for acellular nerve graft: An ex vivo characterization and in vivo evaluation. J. Tissue Eng. Regen. Med. 13, 1241–1252 (2019).
Johnson, P. J., Newton, P., Hunter, D. A. & Mackinnon, S. E. Nerve endoneurial microstructure facilitates uniform distribution of regenerative fibers: A post hoc comparison of midgraft nerve fiber densities. J. Reconstr. Microsurg. 27, 83–90 (2011).
Jesuraj, N. J. et al. Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve 49, 267–276 (2014).
Choi, S. J. et al. Mesenchymal stem cells derived from Wharton’s jelly can differentiate into Schwann cell-like cells and promote peripheral nerve regeneration in acellular nerve grafts. Tissue Eng. Regen. Med. 18, 467–478 (2021).
Ogden, M. A. et al. Safe injection of cultured schwann cells into peripheral nerve allografts. Microsurgery 20, 314–323 (2000).
Hopf, A., Schaefer, D. J., Kalbermatten, D. F., Guzman, R. & Madduri, S. Schwann cell-like cells: Origin and usability for repair and regeneration of the peripheral and central nervous system. Cells 9, 1990 (2020).
Lischer, M. et al. Mesenchymal stem cells in nerve tissue engineering: Bridging nerve gap injuries in large animals. Int. J. Mol. Sci. 24, 7800 (2023).
Williams, A. R. & Hare, J. M. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 109, 923–940 (2011).
Bajada, S., Mazakova, I., Richardson, J. B. & Ashammakhi, N. Updates on stem cells and their applications in regenerative medicine. J. Tissue Eng. Regen. Med. 2, 169–183 (2008).
Jung, N. et al. Tonsil-derived mesenchymal stem cells differentiate into a schwann cell phenotype and promote peripheral nerve regeneration. Int. J. Mol. Sci. 17, 1867 (2016).
Faroni, A. et al. Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death. Cell Death Dis. 4, e743 (2013).
Fong, C. Y. et al. Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. Rep. 7, 1–16 (2011).
El Omar, R. et al. Umbilical cord mesenchymal stem cells: The new gold standard for mesenchymal stem cell-based therapies?. Tissue Eng. B Rev. 20, 523–544 (2014).
Zhang, R. C. et al. Mesenchymal stem cell treatment for peripheral nerve injury: A narrative review. Neural Regen. Res. 16, 2170–2176 (2021).
Jiang, L., Jones, S. & Jia, X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities. Int. J. Mol. Sci. 18, 94 (2017).
Mathot, F., Shin, A. Y. & Van Wijnen, A. J. Targeted stimulation of MSCs in peripheral nerve repair. Gene 710, 17–23 (2019).
Lavorato, A. et al. Mesenchymal stem cell treatment perspectives in peripheral nerve regeneration: Systematic review. Int. J. Mol. Sci. 22, 572 (2021).
Ydens, E. et al. The neuroinflammatory role of Schwann cells in disease. Neurobiol. Dis. 55, 95–103 (2013).
Li, N. & Hua, J. Interactions between mesenchymal stem cells and the immune system. Cell Mol. Life Sci. 74, 2345–2360 (2017).
Li, X. et al. Immunomodulatory effects of mesenchymal stem cells in peripheral nerve injury. Stem Cell Res. Ther. 13, 18 (2022).
Zhang, F., Miao, Y., Liu, Q., Li, S. & He, J. Changes of pro-inflammatory and anti-inflammatory macrophages after peripheral nerve injury. RSC Adv. 10, 38767–38773 (2020).
Murray, P. J. et al. Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41, 14–20 (2014).
Iyer, S. S. & Cheng, G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 32, 23–63 (2012).
Holness, C. L. & Simmons, D. L. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81, 1607–1613 (1993).
Medrek, C., Pontén, F., Jirström, K. & Leandersson, K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer https://doi.org/10.1186/1471-2407-12-306 (2012).
Rios, R., Jablonka-Shariff, A., Broberg, C. & Snyder-Warwick, A. K. Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery. Mol. Cell Neurosci. 111, 103590 (2021).
Porcheray, F. et al. Macrophage activation switching: An asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481–489 (2005).
Chen, X. et al. Exosomes derived from human umbilical cord mesenchymal stem cells regulate macrophage polarization to attenuate systemic lupus erythematosus-associated diffuse alveolar hemorrhage in mice. Int. J. Stem Cells 14, 331–340 (2021).
Jessen, K. R. & Mirsky, R. Negative regulation of myelination: Relevance for development, injury, and demyelinating disease. Glia 56, 1552–1565 (2008).
Cattin, A. L. et al. Macrophage-induced blood vessels guide Schwann cell-mediated regeneration of peripheral nerves. Cell 162, 1127–1139 (2015).
Fawcett, J. W. The extracellular matrix in plasticity and regeneration after CNS injury and neurodegenerative disease. Prog. Brain Res. 218, 213–226 (2015).
Guo, Z. Y. et al. Human umbilical cord mesenchymal stem cells promote peripheral nerve repair via paracrine mechanisms. Neural Regen. Res. 10, 651–658 (2015).
Chao, M. V. Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299–309 (2003).
Funakoshi, H. et al. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol. 123, 455–465 (1993).
Grosheva, M. et al. Comparison of trophic factors’ expression between paralyzed and recovering muscles after facial nerve injury: A quantitative analysis in time course. Exp. Neurol. 279, 137–148 (2016).
McGregor, C. E. & English, A. W. The role of BDNF in peripheral nerve regeneration: Activity-dependent treatments and val66met. Front. Cell Neurosci. 12, 522 (2018).
Zheng, J. et al. BDNF promotes the axonal regrowth after sciatic nerve crush through intrinsic neuronal capability upregulation and distal portion protection. Neurosci. Lett. 621, 1–8 (2016).
Li, R. et al. Nerve growth factor activates autophagy in Schwann cells to enhance myelin debris clearance and to expedite nerve regeneration. Theranostics 10, 1649–1677 (2020).
Kemp, S. W. et al. Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat. Exp. Neurol. 229, 460–470 (2011).
Saio, S. et al. Extracellular environment-controlled angiogenesis, and potential application for peripheral nerve regeneration. Int. J. Mol. Sci. 22, 11169 (2021).
Rosenstein, J. M., Krum, J. M. & Ruhrberg, C. VEGF in the nervous system. Organogenesis 6, 107–114 (2010).
Mohammadi, R., Ahsan, S., Masoumi, M. & Amini, K. Vascular endothelial growth factor promotes peripheral nerve regeneration after sciatic nerve transection in rat. Chin. J. Traumatol. 16, 323–329 (2013).
Xu, Y. et al. Myelin-forming ability of Schwann cell-like cells induced from rat adipose-derived stem cells in vitro. Brain Res. 1239, 49–55 (2008).
Moreira, A., Kahlenberg, S. & Hornsby, P. Therapeutic potential of mesenchymal stem cells for diabetes. J. Mol. Endocrinol. 59, R109–R120 (2017).
Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
Bae, J. Y., Choi, S. J. & Kim, J. K. Comparison of mesenchymal stem cell attachment efficiency in acellular neural graft for peripheral nerve regeneration. J. Plast. Reconstr. Aesthet. Surg. 75, 1674–1681 (2022).
Acknowledgements
The authors thank the members of the Asan Medical Center animal facility and the Stem Cell center, Asan Institute for Life Sciences for providing technical supports.
Funding
This study was supported by the National Research Foundation of Korea, No. NRF-2017R1A2B4003692, NRF-2020R1A2C1006656 (JKK); the Asan Institute for Life Sciences, Asan Medical Center, No. 2019IP0766, 2022IP0049, 2023IP0045 (JKK).
Author information
Authors and Affiliations
Contributions
Y.H.S.: writing the manuscript, data analysis and interpretation; S.J.C.: acquisition of data, writing of the manuscript; J.K.K.: conception and design, critical revision of the manuscript, and final approval of the version to be submitted. Y.H.S. and S.J.C. contributed equally to this study. All authors have read and approved the final submitted manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shin, Y.H., Choi, S.J. & Kim, J.K. Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration. Sci Rep 13, 21214 (2023). https://doi.org/10.1038/s41598-023-48495-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-48495-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.